TY - JOUR
T1 - Lymphoblastic Lymphoma
T2 - Guidelines From the International Lymphoma Radiation Oncology Group (ILROG)
AU - Dabaja, Bouthaina Shbib
AU - Specht, Lena
AU - Yahalom, Joachim
N1 - Publisher Copyright:
© 2018 Elsevier Inc.
PY - 2018/11/1
Y1 - 2018/11/1
N2 - Presentation with a large mediastinal mass is a hallmark of acute lymphoblastic lymphoma, a disease that is treated in the same way as acute lymphoblastic leukemia even in the absence of marrow involvement. The role of mediastinal radiation for patients who achieve complete remission after chemotherapy has been overlooked and controversial. This document presents current knowledge on the role of radiation for lymphoblastic lymphoma and best practices for addressing how to deliver mediastinal radiation with modern technology.
AB - Presentation with a large mediastinal mass is a hallmark of acute lymphoblastic lymphoma, a disease that is treated in the same way as acute lymphoblastic leukemia even in the absence of marrow involvement. The role of mediastinal radiation for patients who achieve complete remission after chemotherapy has been overlooked and controversial. This document presents current knowledge on the role of radiation for lymphoblastic lymphoma and best practices for addressing how to deliver mediastinal radiation with modern technology.
UR - http://www.scopus.com/inward/record.url?scp=85053288872&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85053288872&partnerID=8YFLogxK
U2 - 10.1016/j.ijrobp.2018.05.078
DO - 10.1016/j.ijrobp.2018.05.078
M3 - Review article
C2 - 30238900
AN - SCOPUS:85053288872
SN - 0360-3016
VL - 102
SP - 508
EP - 514
JO - International Journal of Radiation Oncology Biology Physics
JF - International Journal of Radiation Oncology Biology Physics
IS - 3
ER -